Determinants of response to gefitinib (Iressa®, ZD1839) in patients with advanced breast cancer Meeting Abstract


Authors: Iacobuzio-Donahue, C. A.; Albain, K.; Elledge, R.; Gradishar, W.; Hayes, D.; Rowinsky, E.; Hudis, C.; Pusztai, L.; Tripathy, D.; Modi, S.; Rubin, S.; Hidalgo, M.
Abstract Title: Determinants of response to gefitinib (Iressa®, ZD1839) in patients with advanced breast cancer
Meeting Title: 2003 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Journal Title: Clinical Cancer Research
Volume: 9
Issue: 16 Pt. 2
Meeting Dates: 2003 Nov 17-21
Meeting Location: Boston, MA
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2003-12-01
Start Page: 6092s
Language: English
ACCESSION: WOS:000187467300097
PROVIDER: wos
PUBMED: 14712828
Notes: Meeting Abstract: #A96 -- Poster Session A -- Source: Wos
Citation Impact
MSK Authors
  1. Clifford Hudis
    905 Hudis
  2. Shanu Modi
    265 Modi